Candel Therapeutics, Inc. Quarterly Current Ratio in % from Q1 2022 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Candel Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q1 2022 to Q3 2024.
  • Candel Therapeutics, Inc. Current Ratio for the quarter ending September 30, 2024 was 184 %, a 76.8% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 184 -608 -76.8% Sep 30, 2024
Q2 2024 253 -816 -76.3% Jun 30, 2024
Q1 2024 351 -975 -73.5% Mar 31, 2024
Q4 2023 520 -941 -64.4% Dec 31, 2023
Q3 2023 792 -743 -48.4% Sep 30, 2023
Q2 2023 1.07K -631 -37.1% Jun 30, 2023
Q1 2023 1.33K -174 -11.6% Mar 31, 2023
Q4 2022 1.46K Dec 31, 2022
Q3 2022 1.53K Sep 30, 2022
Q2 2022 1.7K Jun 30, 2022
Q1 2022 1.5K Mar 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.